Comparing glue embolization and conservative treatment for pelvic congestion syndrome
Official title: Glue Embolization Versus Conservative Treatment for Pelvic Congestion Syndrome: A Randomized Trial
Run by Tanta University · NCT06560294 · Data updated 2026-11-12
This study is testing whether a new glue treatment works better than standard care for women aged 30 to 50 with pelvic congestion syndrome to help relieve their chronic pelvic pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 50 Years |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta, ElGharbia) |
| Status | Recruiting |
| Started | August 17, 2024 |
| Main results expected | October 1, 2025 |
| Study ends | October 1, 2025 |
| Registry record updated | August 19, 2025 |
| Trial ID | NCT06560294 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 30 to 50 who are experiencing symptoms of pelvic congestion syndrome.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have alternative causes of chronic pelvic pain may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the safety and efficacy of glue embolization compared to conservative treatment methods for pelvic congestion syndrome (PCS), a condition that causes chronic pelvic pain in women. The study will involve women aged 30 to 50 who experience symptoms of PCS. Participants will receive either the micronized purified flavonoid fraction (Daflon) or undergo glue embolization to occlude incompetent pelvic veins. The outcomes will be assessed to determine which treatment provides better relief from symptoms.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for women suffering from pelvic congestion syndrome.
How similar studies have gone: While traditional conservative treatments have been used for PCS, the approach of glue embolization is relatively novel and has not been extensively tested in similar studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged from 30 to 50 years. * Complaining from pelvic congestion syndrome. Exclusion Criteria: * Pregnant women at any gestational age, women who gave birth less than 12 months ago, and breastfeeding mothers. * Patients who are treated with opiates to reduce pelvic pain in the period before the study. * Patient with history of contrast allergy * Patient with renal impairment * Patient has alternative gynecological cause of chronic pelvic pain as pelvic inflammatory disease (PID), endometriosis, fibroid, adenomyosis, ovarian cyst * Patient underwent any previous intervention for pelvic congestion syndrome as laparoscopy or surgery.
Where it's running
-
Tanta University
Tanta, ElGharbia, Egypt Recruiting
Study contacts
- Study coordinator: Mohamed I Eleissawy, MD
- Email: mohamed.elesawy@med.tanta.edu.eg
- Phone: 00201110036328
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Endovascular Embolization for Pelvic Congestion Syndrome in Women
This study tests whether endovascular embolization can relieve chronic pelvic pain and improve quality of life for women with pelvic congestion syndrome.
-
Oral N-Acetylcysteine for Diabetic Macular Edema
This study tests whether taking N-acetylcysteine by mouth can help people with center-involving diabetic macular edema who don’t yet need anti-VEGF therapy.
-
3D-Printed versus Conventional Palatal Cribs for Tongue Thrust in Children
This study tests whether a 3D-printed cobalt-chromium palatal crib works better than a traditional soldered stainless steel crib to help kids stop tongue thrusting.
-
Dia-Root Bio MTA vs MTA Plus forIndirect Pulp Capping in Young Permanent Molars
This trial tests whether Dia-Root Bio MTA works as an indirect pulp cap in kids’ first permanent molars better or similar to standard MTA Plus.
-
Nanohydroxyapatite vs Fluoride Varnish for MIH Front Teeth
This trial tests whether a nanohydroxyapatite varnish can remineralize MIH-affected front teeth in 8–11 year-olds as effectively as a standard 5% fluoride varnish.
-
Lactium premedication to see if it prevents emergence agitation after adenotonsillectomy
A preoperative dose of Lactium is tested to see if it prevents emergence agitation in children after adenotonsillectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.